ChinaDaily Briefs

China: Orient Overseas International, First Pacific Co, MINISO Group Holdings, Medlive Technology, Road King Infrastructure and more

In today’s briefing:

  • HSI Index Rebalance Preview: Will The Pace of Inclusions Pick Up?
  • First Pac (142 HK): Perennially Inexpensive
  • Miniso to Increase Liquidity Via a Dual Primary Listing on HKEX
  • Medlive Technology (2192.HK) – The Logic Has Shaken
  • Morning Views Asia: China SCE, Road King Infrastructure, Sino-Ocean Service, Sunac China Holdings

HSI Index Rebalance Preview: Will The Pace of Inclusions Pick Up?

By Brian Freitas

  • Current at 66 constituents, we expect to reach 80 HSI INDEX constituents by the end of the year before moving higher towards 100 index members in 2023.
  • We list 10 stocks that could be added to the index in June – with one-way turnover close to 6%, the actual number of inclusions will be lower.
  • We also list out another 8 stocks that could possibly be added in June, though the probability of a September/ December inclusion is higher.

First Pac (142 HK): Perennially Inexpensive

By David Blennerhassett

  • Last week First Pacific Co (142 HK) announced a 33% increase in recurring profit to a record high.
  • The full-year distribution up to 19.0 HK cents/share backs out a yield of 6.3%.
  • The current discount to NAV of 56% compares with a 12-month average of 59%, and a long-term average of 50%.

Miniso to Increase Liquidity Via a Dual Primary Listing on HKEX

By Oshadhi Kumarasiri

  • Last week, MINISO Group Holdings (MNSO US) filed an application to conduct a follow-on public offering of ordinary shares on the main board of the Hong Kong Stock Exchange.
  • The Hong Kong listing will be treated as a second primary listing, resulting in a substantial improvement in the stock’s liquidity.
  • With the improvement in liquidity following the Hong Kong offer, there could be a significant upside to Miniso shares in the short term.

Medlive Technology (2192.HK) – The Logic Has Shaken

By Xinyao (Criss) Wang

  • The revenue YoY growth, net profit YoY growth and net profit margin reached a new low in 2021. The performance of Medlive cannot meet the market’s expectations of high growth.
  • The medical knowledge solutions is the cornerstone business and vital to the attractiveness of platform for users. However, this business is not strong enough to make the outlook certain.
  • In the fierce competition, more efforts are needed on how to convert physician resources into business value continuously. Due to unreliable logic, we are conservative about Medlive at current stage.

Morning Views Asia: China SCE, Road King Infrastructure, Sino-Ocean Service, Sunac China Holdings

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma